s-adenosylmethionine has been researched along with benserazide in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Black, MJ; Brandt, RB | 1 |
Baldessarini, RJ; Greiner, E | 1 |
Gulliver, PA; Hagan, RM; Raxworthy, MJ | 1 |
Fukazawa, H; Funaki, T; Kuruma, I; Onodera, H; Tagami, C; Tsukamoto, Y; Ushiyama, N | 1 |
Da Prada, M; Dingemanse, J; Zürcher, G | 1 |
5 other study(ies) available for s-adenosylmethionine and benserazide
Article | Year |
---|---|
Nicotinic acid or N-methyl nicotinamide prolongs elevated brain dopa and dopamine in L-dopa treatment.
Topics: Animals; Benserazide; Brain Chemistry; Dihydroxyphenylalanine; Dopamine; Levodopa; Liver; Male; Niacinamide; Nicotinic Acids; Rats; Rats, Inbred Strains; S-Adenosylmethionine | 1986 |
Inhibition of catechol-O-methyl transferase by catechols and polyphenols.
Topics: Animals; Benserazide; Brain; Catechol O-Methyltransferase Inhibitors; Catechols; Dihydroxyphenylalanine; Kinetics; Liver; Male; Methylation; Myocardium; Norepinephrine; Normetanephrine; Phenols; Polymers; Pyrogallol; Rats; S-Adenosylmethionine; Tritium | 1973 |
Benserazide and carbidopa as substrates of catechol-O-methyltransferase: new mechanism of action in Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benserazide; Benzyl Compounds; Carbidopa; Catechol O-Methyltransferase; Hydrazines; Kinetics; Liver; Parkinson Disease; S-Adenosylmethionine; Substrate Specificity; Swine | 1980 |
Lack of an effect of Madopar on the disposition of tolcapone and its 3-O-methylated metabolite in rats.
Topics: Animals; Benserazide; Benzophenones; Biotransformation; Catechol O-Methyltransferase Inhibitors; Drug Combinations; Enzyme Inhibitors; Half-Life; Injections, Intravenous; Levodopa; Male; Methylation; Nitrophenols; Rats; Rats, Sprague-Dawley; S-Adenosylmethionine; Tissue Distribution; Tolcapone | 1995 |
Potent COMT inhibition by Ro 40-7592 in the periphery and in the brain. Preclinical and clinical findings.
Topics: Animals; Benserazide; Benzophenones; Brain; Carbidopa; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Dose-Response Relationship, Drug; Erythrocytes; Homovanillic Acid; Humans; Levodopa; Male; Nitrophenols; Peripheral Nerves; Rats; S-Adenosylhomocysteine; S-Adenosylmethionine; Tolcapone | 1993 |